Position in LLY
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$18,068,215
+$11,032,895 QoQ
Shares Held
15,064
+96.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#936
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Welch Group, LLC holds $262,604,589 across 9 Drug Manufacturers - General names. LLY ranks #4 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
371,366 | $93,450,540 | |
| 2 | JNJ |
Johnson & Johnson
|
356,484 | $90,536,241 | |
| 3 | PFE |
Pfizer Inc
|
2,194,625 | $52,846,570 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
15,064 | $18,068,215 | |
| 5 | MRK |
Merck & Co., Inc.
|
37,231 | $4,784,183 | |
| 6 | NVS |
Novartis AG
|
7,262 | $1,138,100 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
13,167 | $758,682 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,699 | $593,671 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,068,215 | 15,064 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $7,035,320 | 7,649 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $8,259,991 | 7,686 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $5,733,182 | 7,514 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $5,074,740 | 6,510 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $5,314,730 | 6,435 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $5,018,000 | 6,500 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $5,801,135 | 6,548 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $5,739,203 | 6,339 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $4,621,860 | 5,941 | Shares | Sole | 2024-04-09 | |
| 2023-12-31 | $3,088,893 | 5,299 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $2,963,346 | 5,517 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $2,564,851 | 5,469 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $1,966,079 | 5,725 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $2,147,114 | 5,869 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $1,883,190 | 5,824 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $2,086,095 | 6,434 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $1,842,504 | 6,434 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $1,641,851 | 5,944 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $1,416,798 | 6,132 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $1,407,416 | 6,132 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $1,145,580 | 6,132 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $891,644 | 5,281 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $696,730 | 4,707 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $789,213 | 4,807 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $513,957 | 3,705 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||